Sun Pharma Advanced Research Co (BOM:532872) EPS (Basic) : ₹-10.56 (TTM As of Mar. 2025)

View and export this data going back to 2007. Start your Free Trial

What is Sun Pharma Advanced Research Co EPS (Basic)?

Sun Pharma Advanced Research Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2025 was ₹-1.84. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹-10.56.

Sun Pharma Advanced Research Co's EPS (Diluted) for the three months ended in Mar. 2025 was ₹-1.84. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹-10.56.

Sun Pharma Advanced Research Co's EPS without NRI for the three months ended in Mar. 2025 was ₹-1.84. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was -10.56.

During the past 3 years, the average EPS without NRI Growth Rate was -10.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was -4.20% per year. During the past 10 years, the average EPS without NRI Growth Rate was -15.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Sun Pharma Advanced Research Co's highest 3-Year average EPS without NRI Growth Rate was 21.00% per year. The lowest was -99.40% per year. And the median was -22.40% per year.

Sun Pharma Advanced Research Co EPS (Basic) Historical Data

The historical data trend for Sun Pharma Advanced Research Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sun Pharma Advanced Research Co EPS (Basic) Chart

Sun Pharma Advanced Research Co Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

EPS (Basic)

Get a 7-Day Free Trial

-5.77

-7.73

-7.82

-11.93

-10.55

Sun Pharma Advanced Research Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EPS (Basic)	Get a 7-Day Free Trial															-3.26	-2.96	-3.31	-2.45	-1.84

Sun Pharma Advanced Research Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Sun Pharma Advanced Research Co's Basic EPS for the fiscal year that ended in Mar. 2025 is calculated as

Basic EPS (A: Mar. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-3425.1	-	0)	/	324.654
	=	-10.55

Sun Pharma Advanced Research Co's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-597.7	-	0)	/	324.770
	=	-1.84

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-10.56

Sun Pharma Advanced Research Co (BOM:532872) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Sun Pharma Advanced Research Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Sun Pharma Advanced Research Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Sun Pharma Advanced Research Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharma Advanced Research Co Ltd (BOM:532872) » Definitions » EPS (Basic)

Traded in Other Exchanges

SPARC:India

Address

Off Mahakali Caves Road, 17-B, Mahal Industrial Estate, Andheri (East), Mumbai, MH, IND, 400093

Website

https://www.sparc.life

Sun Pharma Advanced Research Co Ltd is an Indian specialty and generic drug manufacturing company. The company has identified pharmaceuticals research and development as its only reportable segment. The company is focused on drug discovery in focused therapy areas such as cancer and anti-inflammatory treatments. The company considers merger and acquisition investment as a potential component of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities. It derives maximum revenue from India and also has its presence in othe4r countries.

Sun Pharma Advanced Research Co Headlines

No Headlines